Design, development and characterization of buccal bioadhesive films of Doxepin for treatment of odontalgia

H Castán, MA Ruiz, B Clares, ME Morales - Drug delivery, 2015 - Taylor & Francis
Tricyclic antidepressants, as doxepin hydrochloride (DH), may have analgesic local effect
due to its biochemical mechanism of action. Delivery of DH directly to the oral cavity could …

Modified biomolecule as potential vehicle for buccal delivery of doxepin

F Laffleur, M Zilio, D Shuwisitkul - Therapeutic Delivery, 2016 - Taylor & Francis
Aim: Doxepin is a traditional tricyclic antidepressant with analgesic and anesthetic
properties when applied topically to the mucosa. Doxepin is one approach in treating …

Optimization and evaluation of chitosan buccal films containing tenoxicam for treating chronic periodontitis: In vitro and in vivo studies

LY Ashri, F Amal El Sayeh, MA Ibrahim… - Journal of Drug Delivery …, 2020 - Elsevier
The objective of the present study was to optimize and evaluate a buccal mucoadhesive
tenoxicam (TNX) local delivery system for the treatment of chronic periodontitis. Full 3 2 …

Development of a buccal doxepin platform for pain in oral mucositis derived from head and neck cancer treatment

R Sanz, AC Calpena, M Mallandrich, Á Gimeno… - European Journal of …, 2017 - Elsevier
This study describes the development of semisolid formulations containing doxepin (DOX)
for pain relief in oral mucositis, frequently related to chemotherapy and/or radiotherapy …

Bioadhesive okra polymer based buccal patches as platform for controlled drug delivery

G Kaur, D Singh, V Brar - International journal of biological …, 2014 - Elsevier
In the present investigation, polysaccharide from the Okra fruits (Hibiscus esculentus) was
extracted, characterized and explored for its mucoadhesive potential. Mucoadhesive films of …

Formulation and evaluation of chitosan-based buccal bioadhesive films of zolmitriptan

R Kumria, BE Al-Dhubiab, J Shah, AB Nair - Journal of Pharmaceutical …, 2018 - Springer
Purpose Therapeutic efficacy of zolmitriptan in oral therapy is primarily limited by the
biopharmaceutical issues. The objective of this study is to design and optimize chitosan …

Dexamethasone sodium phosphate-loaded Chitosan based delivery systems for buccal application

R Pignatello, AHS Stancampiano… - Journal of drug …, 2007 - Taylor & Francis
Chitosan (CH) was used as a biocompatible and bioadhesive polymer material to prepare
solid dispersions as well as hydrogels loaded with dexamethasone sodium phosphate …

[引用][C] Formulation and evaluation of pimozide buccal mucoadhesive patches

B Basu, K Garala, J Thimmasetty - International Journal of …, 2009 - ijpsnonline.com
Within the oral mucosal cavity, the buccal region offers an attractive route of administration
for systemic drug delivery. Pimozide patches were prepared using HPMC (15 & 47 cPs) …

[PDF][PDF] Formulation and in-vitro evaluation of mucoadhesive buccal films of zolmitriptan

NG Rao, MR Munde - J Pharm Res, 2011 - Citeseer
The zolmitriptan is a serotonin (5-HT1) agonist used for the treatment of migraine with or
without aura. The absolute oral bioavailability is about 40 to 50%. The half-life of zolmitriptan …

Mucoadhesive poloxamer-based hydrogels for the release of HP-β-cd-complexed dexamethasone in the treatment of buccal diseases

R Diaz-Salmeron, B Toussaint, N Huang… - Pharmaceutics, 2021 - mdpi.com
Oral lichen planus (OLP) is an ongoing and chronic inflammatory disease affecting the
mucous membrane of the oral cavity. Currently, the treatment of choice consists in the direct …